logo
logo

Angiocrine Bioscience announced it raised $2.1 Million in an initial filing from an offering of $3 Million

Sep 05, 202515 days ago

Amount Raised

$2.1 Million

Round Type

seed

San DiegoBiotechnology

Company Information

Company

Angiocrine Bioscience

Location

11585 SORRENTO VALLEY RD, STE 109

San Diego, California, United States

About

Angiocrine Bioscience is a private, clinical stage engineered cell therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions. Our team is developing a pipeline of proprietary engineered endothelial cell (E-CEL® ) therapies for treating multiple life-threatening hemato-oncologic and immunologic conditions, as well as, regenerating tissues and organs that have been injured or damaged by diseases.

Related People